ĚÇĐÄÍřŇł°ć

24 January 2024

LiU researchers Neil Lagali and Mehrdad Rafat earn global acclaim, winning ARVO Foundation's 2023 Point of View Award. Recognized by the world's largest eye research organization, their groundbreaking work in regenerative ophthalmology offers new hope for vision restoration.

Neil Lagai and Mehrdad Rafat. Photographer: Thor Balkhed

The Association for Research in Vision and Ophthalmology (ARVO) Foundation announced the laureates of the 2023 Point of View Award. Neil Lagali, professor from Linköping University, and Mehrdad Rafat, adjunct senior lecturer from Linköping University and founder of LinkoCare Life Sciences AB /NaturaLens AB, Sweden, have been recognized for their remarkable work in regenerative ophthalmology. This prestigious accolade acknowledges outstanding scholarly contributions to the realm of vision restoration and the award provides a $20,000 cash prize.

Lagali and Rafat's award-winning article

Lagali and Rafat's groundbreaking article, titled '' (Nature Biotechnology; Aug. 11, 2022), addresses the challenges of treating advanced keratoconus (a condition when the normally round cornea becomes thin and develops a cone-like bulge). Their innovative approach involves bioengineering implantable corneal tissue and utilizing a less invasive surgical method. This method successfully restored vision to legally blind patients with advanced keratoconus, some achieving 20/20 vision postoperatively.

Future steps and global impact

Close up of eye and femtolaser.Close up of eye and femtolaser. Photo credit Thor Balkhed Neil Lagali expresses gratitude for the award, emphasizing its role in setting up larger clinical trials to validate the approach in a broader patient population.

"This we hope will ultimately lead to an off-the-shelf solution for corneal implantation that does not depend on donated tissue or eye banks, that could potentially benefit many people globally. I have dedicated my research career to helping to treat or prevent vision impairment and loss, and this award motivates me to continue to pursue these efforts," says Lagali.

Rafat adds that "This award means a lot to me and my team as it recognizes 20 years of our research and development activities toward developing a new device that can help people who are suffering from corneal blindness and impaired vision."

The accolade is expected to attract expertise, investors, and industry professionals, advancing the necessary clinical trials, regulatory processes, certification, and scaled-up production for the project's success.

Advancing eye research globally

As the largest eye and vision research organization globally, ARVO continues to champion research into understanding the visual system and addressing its disorders. The Point of View Award, established by the Point of View Foundation, aligns with ARVO's mission to support groundbreaking research efforts that contribute to the prevention, treatment, and cure of eye-related disorders.

About ARVO

The Association for Research in Vision and Ophthalmology (ARVO) boasts a membership of approximately 10,000 eye and vision researchers from over 75 countries. Learn more at .

Established in 2001, the ARVO Foundation for Eye Research raises funds to support ARVO’s education and career development resources for eye and vision researchers. Learn more at .

Contact

More about the research

Latest news from LiU

En person med färgglada skor som ligger på gräset.

LiU world leader in football injury research

A new study mapping more than 120 years of research ranks LiU number one. It shows that LiU has published the most scientific works in the field and is among the world's most cited and influential research institutions.

A couple of people sitting at a desk in front of a computer.

How childhood liver tumor cells acquire different features

Researchers have discovered how the so called Wnt signaling pathway can result in tumor cells with different features within a single tumor. Their findings contribute to better classification of these tumors.

En närbild av en man som bär glasögon.

David Engblom wins award for his research on how our brains make us feel ill

David Engblom, Professor of Neurobiology, is awarded the 2026 Onkel Adam Prize for outstanding research at the Faculty of Medicine. He researches the role of the brain in making us feel ill in various medical conditions.